<?xml version="1.0" encoding="UTF-8"?>
<p id="Par9">Data from adults reveal that severe cases often develop dyspnea one week after disease onset. Severe cases may rapidly progress to acute respiratory distress syndrome (ARDS), septic shock, refractory metabolic acidosis, and coagulation dysfunction [
 <xref ref-type="bibr" rid="CR6">6</xref>, 
 <xref ref-type="bibr" rid="CR7">7</xref>]. Although no deaths in children have been reported up to now, the potential risk of death should be highlighted. Though clinical symptoms in pediatric patients are relatively milder compared with those in adult patients, ARDS and death cases also occurred in infected children during the SARS and MERS epidemics [
 <xref ref-type="bibr" rid="CR8">8</xref>â€“
 <xref ref-type="bibr" rid="CR11">11</xref>].
</p>
